- Capital Cube•11 days agoTaro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q3, 2017 By the Numbers : February 13, 2017
Categories: Yahoo Finance Get free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Pfizer Inc., Merck & Co., Inc., Johnson & Johnson, GlaxoSmithKline plc Sponsored ADR and Novartis AG Sponsored ADR (PFE-US, MRK-US, JNJ-US, GSK-US ... Read more (Read more...)
- Investopedia•14 days ago
Taro Pharmaceutical's third-quarter earnings and sales fell compared to last year.
- Associated Press•14 days ago
On a per-share basis, the Haifa Bay, Israel-based company said it had net income of $3.42. The drug maker posted revenue of $220.4 million in the period. Taro shares have climbed almost 1 percent since ...
TARO : Summary for Taro Pharmaceutical Industries - Yahoo Finance
Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||114.61 - 119.49|
|52 Week Range||92.28 - 152.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||10.20|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|